NEW YORK (GenomeWeb) – Invitae reported after the close of the market on Wednesday a 106 percent year-over-year increase in third quarter revenues driven by 95 percent growth in testing volume.

For the three months ended Sept. 30, the company posted $37.4 million in revenue, up from $18.1 million in Q3 of 2017, and beating the consensus Wall Street estimate of $34.7 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.